Next Sequence

At Kresko we believe that the time has come to apply RNA technologies to address today´s health challenges by improving our nutrition. We want people to think of food not only as a source of nutrients but also as essential information for adaptation and self-development.

New Wave Biotech is developing computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. By doing this, they aim to accelerate the sustainable transformation of food production.

Reshape is building the next generation of biotech laboratories. We automate everything from filling plates to analyzing images to allow researchers and engineers to spend their time more efficiently

Alora is the next frontier ocean agriculture company building a platform to produce enough food for 10 billion people while using no freshwater, no chemical fertilisers or pesticides and very little land.

Enzymity is a bioplatform developing a method for breaking down polymers such as plastics and resins into monomers with the help of synthetic enzymes. The enzymes are tailored for specific types of material (e.g. PET or synthetic rubber) and are produced by genetically modified microorganisms. The monomers which result from the process can be used to create new virgin polymers, thus reducing the need for fossil fuel derived plastics/resins. This cycle can be repeated many times and does not deteriorate the quality of the material, as opposed to the currently prevalent mechanical recycling.

Trident Bioscience builds tools to expedite the discovery and optimization of useful proteins. By combining technologies, they're closing the design-build-test loop of protein optimization and cutting the total cycle time to help bring game changing proteins to market faster than ever before.

Sentient Med is a digital healthcare company focused on improving digital pathology and medical modalities through cutting-edge machine learning to create tailor-made synthetic image datasets for the purpose of overcoming bias and other data limitations and deliver valuable images that are free of any privacy concern.

Rejuvenate Bio is developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies and developing treatments to reverse aging and address multiple age-related diseases.

Psylo is a drug development company focused on next generation psychedelics; Their goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. They are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.

OSbiome is a personalised digital health company that combines gut microbiome technology with AI to provides bespoke (and simple) nutrition and lifestyle recommendations to improve your gut health and overall wellness.